Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 4/20 | 0.47 |
| ▸ | F2 | P00734 | 9/20 | 0.38 |
| ▸ | ASIC3 | Q9UHC3 | 2/20 | 0.37 |
| ▸ | F10 | P00742 | 6/20 | 0.36 |
| ▸ | PLG | P00747 | 6/20 | 0.36 |
| ▸ | PLAU | P00749 | 6/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.36 |
| ▸ | PLAT | P00750 | 2/20 | 0.36 |
| ▸ | HPN | P05981 | 1/20 | 0.36 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.36 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.36 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.36 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.35 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.35 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12711172 | 0.77 | PRMT1 (0.65) | PRMT1F2F10TPSAB1TPSD1 | |
| SCHEMBL8238372 | 0.69 | PRMT1 (0.64) | PRMT1F2ASIC3F10PLG | |
| SCHEMBL8229704 | 0.64 | PRMT1 (1.00) | PRMT1F2F10 | |
| SCHEMBL8235618 | 0.64 | PRMT1 (0.84) | PRMT1F2F10TPSAB1TPSD1 | |
| SCHEMBL8238374 | 0.63 | PRMT1 (1.00) | PRMT1F2 | |
| SCHEMBL7906683 | 0.63 | F2 (0.58) | F2ASIC3F10PLGPLAU | |
| SCHEMBL12711187 | 0.63 | PRMT1 (0.46) | PRMT1F2ASIC3F10PLG | |
| SCHEMBL5512603 | 0.62 | PRMT1 (0.83) | PRMT1F2F10PLGPLAU | |
| SCHEMBL10143894 | 0.61 | CYP2A6 (0.52) | F2ASIC3F10PLGPLAU | |
| SCHEMBL10143895 | 0.61 | DYRK1A (0.39) | PRMT1F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086877-A1 | Small Molecule Inhibitors of Botulinum Neurotoxins | BAVARI SINA | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086877-A1 | Small Molecule Inhibitors of Botulinum Neurotoxins | ACHE, MMP2, TIMP3 | PRMT1 2768/4885F2 521/4885ASIC3 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.